Biotech & pharma
Scientists find cells that mend broken heart
01 Apr 2010
Researchers create atlas of transcription factor combinations
By By Debra Kain | 15 Mar 2010
Protein shown to be natural Inhibitor of aging in fruit fly model
By By Debra Kain | 06 Mar 2010
Panacea Biotec develops Swine flu vaccine
03 Mar 2010
Stem cells rescue nerve cells by direct contact
22 Feb 2010
Genetic variant linked to biological ageing
19 Feb 2010
Scientists report breakthrough in HIV treatment
01 Feb 2010
US and British scientists claim to have grown a crystal that helped them unravel the structure of an enzyme called integrase, found in retroviruses like HIV.
Researchers create new 'smart' nanocapsule delivery system for use in protein therapy
21 Jan 2010
Nanocapsules are submicroscopic containers composed of an oily or aqueous core surrounded by a thin, permeable polymer membrane roughly several to tens of nanometers thick By Wileen Wong Kromhout
Generating understanding more important than generating information: Nobel laureate Ramakrishnan
06 Jan 2010
Australian-American-British trio share Nobel for medicine
05 Oct 2009
Elizabeth H Blackburn, Carol W Greider and Jack W Szostak have jointly won the 2009 Nobel Prize in physiology or medicine for their work on `how chromosomes are protected by telomeres and the enzyme telomerase.
Genomic analysis links modern Indians to two ancestral populations
25 Sep 2009
New genomic research by scientists at the Centre for Cellular and Molecular Biology in Hyderabad and the Harvard Medical School in the US has revealed that nearly all Indians carry genomic contributions from two distinct ancestral populations.
Malignant signature may help identify patients likely to respond to therapy
09 Sep 2009
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. By Steve Benowitz, director of communications, Cancer Centre, University of California, San Diego
Malignant signature may help identify patients likely to respond to therapy
09 Sep 2009
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. By Steve Benowitz, director of communications, Cancer Centre, University of California, San Diego
Glenmark, Forest drug trial for COPD fails
19 Aug 2009
Latest articles
Featured articles
Server CPU Shortages Grip China as AI Boom Strains Intel and AMD Supply Chains
By Cygnus | 06 Feb 2026
Intel and AMD server CPU shortages are hitting China as AI data center demand surges, pushing lead times to six months and driving prices higher.
Budget 2026-27 Seeks Fiscal Balance Amid Rupee Volatility and Industrial Stagnation
By Cygnus | 02 Feb 2026
India's Budget 2026-27 targets fiscal discipline with record capex as markets tumble, the rupee weakens and manufacturing struggles to regain momentum.
The Thirsty Cloud: Why 2026 Is the Year AI Bottlenecks Shift From Chips to Water
By Axel Miller | 28 Jan 2026
As AI server density surges in 2026, data centers face a new bottleneck deeper than chips — the massive water demand required for cooling next-generation infrastructure.
The New Airspace Economy: How Geopolitics Is Rewriting Aviation Costs in 2026
By Axel Miller | 22 Jan 2026
Airspace bans, sanctions and corridor risk are forcing airlines into costly detours in 2026, raising fuel burn, reducing aircraft utilisation and pushing airfares higher worldwide.
India’s Data Center Arms Race: The Battle for Power, Cooling, and AI Real Estate
By Cygnus | 22 Jan 2026
India’s data centre boom is turning into an AI arms race where power contracts, liquid cooling and fast commissioning decide the winners across Mumbai, Chennai and Hyderabad.
India’s Oil Balancing Act: Refiners Rebuild Middle East Supply Lines as Russia Flows Disrupt
By Axel Miller | 21 Jan 2026
India’s refiners are rebalancing crude sourcing as Russian imports fell to a two-year low in December 2025, lifting OPEC’s share and raising geopolitical risk concerns.
Arctic Fever: How ‘Greenland Tariff’ Politics Sparked a Global Flight to Safety
By Axel Miller | 20 Jan 2026
Greenland-linked tariff threats have injected fresh uncertainty into transatlantic trade, triggering a risk-off shift in markets and reshaping global supply chain planning.
The New Oil (Part 5): Friend-Shoring, Supply Chain Fragmentation and the Cost of Resilience
By Cygnus | 19 Jan 2026
Friend-shoring is reshaping lithium, rare earth and graphite supply chains, creating a resilience premium and new winners and losers in clean tech.
The New Oil (Part 4): Can Technology Break the Dependency?
By Cygnus | 16 Jan 2026
Can magnet recycling and rare-earth-free motors reduce global dependence on strategic minerals? Part 4 explores breakthroughs, limits and timelines.

